FDA drug approval lifts biotech Neuren to $1b valuation

MELBOURNE: Biotech Neuren Pharmaceuticals surged to a $1 billion valuation yesterday after the ... read more

Rex posts another loss but revenue on the top

WAGGA WAGGA: Rex has failed to join rivals Qantas and Virgin Australia on ... read more

Donut King owner raises $45m in bid to stay liquid

SYDNEY: Listed franchisee business Retail Food Group has put a $45 million raising ... read more

US Wendy’s move into Australian market hits snag

SYDNEY: Whether or not the cult US brand Wendy’s comes to Australia may ... read more